Featuring Jeff Flake (R-AZ), United States Senator; Dave Brat (R-VA-7), United States Congressman; Michael F. Cannon, Director of Health Policy Studies, Cato Institute; John C. Goodman, President, Goodman Institute for Public Policy Research; moderated by Peter Russo, Director of Congressional Affairs, Cato Institute.
In Lukewarming: The New Climate Science that Changes Everything, Pat Michaels and Chip Knappenberger explain the real science and spin behind the headlines and come to a provocative conclusion: global warming is not hot—it’s lukewarm. Climate change is real, it is partially man-made, but it is clearer than ever that its impact has been exaggerated—with many predictions now being rendered implausible or impossible. This new paperback edition of the book is an expanded edition of last year’s ebook-only edition of Lukewarming, and includes updates in science and policy following the accords reached at the 2015 United Nations Climate Change Conference in Paris.
The Cato Institute has released its 2015 Annual Report, which documents a dynamic year of growth and productivity. The thousands of individuals who contribute to Cato are passionate about freedom and committed to ensuring that future generations enjoy the blessings of liberty, unencumbered by an overreaching state that seeks to control their lives. This is Cato’s optimistic vision for the future, and it would be unimaginable without the Institute’s longstanding partnership with its Sponsors. We will continue our diligence and dedication to seeing this vision realized.
What’s Right and Wrong About the Senate Medicare Bill?
Featuring Michael O’Grady, Senior Health Economist, Joint Economic Committee; Tom Miller, Director, Health Policy Studies, Cato Institute; and John Goodman, President, National Center for Policy Analysis.
Will a Republican Congress and President Bush approve “the biggest expansion of government health benefits since the Great Society”? Yes, says Bill Clinton’s former administrator of the Medicare program, Nancy-Ann DeParle. Her advice on pending legislation to provide prescription drug benefits to seniors: “Democrats should do everything they can to whisk it to his desk.” The Senate is debating the Prescription Drug and Medicare Improvement Act this week. The House will take up a similar measure next week. Our panel will examine the following issues:
Should taxpayers spend $400 billion (or more) over the next eight years — and far more in the decade after that — to finance expanded drug benefits for Medicare recipients? Will this year’s version of Medicare reform deliver more market-based health care to seniors? Or will Medicare reform simply mean more money spent on an expanded version of the traditional program? Are there viable alternatives for overhauling Medicare and improving seniors’ health care options?